Feb 232018
 

CEO opportunity for a Chartered Director.

chartered directorI have been asked to identify a Chartered Director who is expert in the extraction industry to head up a new organisation which will exploit a novel solution to recovering elements from waste developed in a German University.

Initially the requirement would be to arrange for independent verification that the technology works through testing at an internationally respected test house. Given the green light then the task would be to set up an international operation based in the UK. The principals regard the UK as the best base to start technologically based business.

If you are interested and want to be considered, please initially contact Alan Hindley C Dir by e-mail at alan@cedar-associates.com

The technology is summarised below.

CEE Clean Element Extraction OPPORTUNITY

  • A cost effective, global solution to ‘clean-up’ environment damaging, heavy industrial processes
  • Developed in Germany, with all R&D completed and technology patents registered
  • Facilitating the emergence of a new industry with applications across multiple market sectors
  • Company registered and carrying out ‘soft operations’ in Germany

TECHNOLOGY CEE

is a patented process of Clean Element Extraction, which can be summarized as:

  • Clean - a safe, non-toxic, environmentally friendly process
  • Element - applicable to any element, or group of elements
  • Extraction - with close to 100% yield of targeted element/s extracted from any medium

CEE RELEVANT INDUSTRIES

  • Oil & Gas
  • Rare Earth Elements (REE)
  • Precious Metals (Gold, Silver, Platinum etc.)
  • Metals
  • Toxic Waste

GAME CHANGER FOCUS ON OIL & GAS - FRACKING: FLOWBACK CLEAN-UP

Fluid referred to as ‘flowback', a bi-product of fracking that contains toxic and radioactive materials, like Radon, present significant challenges that are both costly and hazardous to the company and the environment. Legal requirements are enforced to ensure ‘flowback’ is treated to achieve a standard equitable with drinking water before this fluid is legally allowed to be released into the water table. CEE technology provides a safe, non toxic and cost effective solution to treat ‘flowback’ to achieve the required quality for release into the water systems, significantly reducing the challenges currently being faced by all fracking companies worldwide. This would initiate a significant advancement for the process, which ordinarily faces strong opposition from governments and environmental agencies and therefore generate both cost and operational gains.

OTHER APPLICATIONS

  • Rare Earth Element Extraction - These elements are critical to the development and production of modern green energy technologies, high-tech defense systems, computers, mobile telephones and advanced IT. Meanwhile, rare earth extraction is one of the most environmentally destructive and toxic of all mining practices. Excessive rare earth mining has resulted in landslides, clogged rivers, environmental pollution emergencies and disasters, causing great damage to people's safety and the ecology of the environment. However, CEE totally transforms this process. Precious
  • Metal Extraction - Traditionally, the process of extracting valuable metals like gold, silver and palladium uses sodium cyanide, which is related to extensive environmental hazards. However, with CEE the use of sodium cyanide is completely avoided making the process both clean and safe, whilst yielding nearly 100% extraction rate. Also, the processing time of CEE is one day per cycle, compared to 7-30 days for the traditional process using sodium cyanide.
  • Oil Extraction - From oil shale, oil sand, oil sludge and oil containing waste materials as metal processing waste - the worldwide known deposits of useable oil shale near the surface could replace crude oil and gas for hundreds of years. However, current technologies are costly and immensely damaging to the environment and not competitive. CEE however, can extract oil from these conditions with nearly 100% yield, is environmentally safe and cost effective.
  • Other Extractions - Tungsten carbide, cobalt, uranium, vanadium, phosphates and alumina-silicates.
  • Toxic Clean Up - CEE can also clean toxic waste stockpiles, extracting the poison and toxic substances, and uncovering usable rare earth elements and precious metals, turning toxic waste into an asset with monetary value and sellable material.
Feb 092018
 

FORMER housing boss Alan Crowe is to be the Royal Ulster Agricultural Society's new chief executive in time for this year's Balmoral Show.

He spent nearly 14 years as chief executive for Northern Ireland Co-Ownership Housing and its subsidiary Own-Co, a regional public body under the Department for Communities and Local Government.

A chartered director, he holds multiple awards and Fellowships with several professional bodies and has worked extensively with regional/central and local government.

He and his family currently live in Portstewart, and his wife, a farmer's daughter is co-owner of a farm in Co Tyrone.

Alan himself spent several years working for the National Farmers' Union and Mutual.

Following his appointment he said:

"I'm delighted and excited to be returning to work within the agricultural sector and look forward to working with the team at the Royal Ulster Agricultural Society."

He now begins a period of gradual transfer of responsibilities from current chief executive Colin McDonald, and it is expected that Alan will take up his new role to coincide with the 150th Balmoral Show in May.

Jul 112017
 

RoSPA appoint Chartered Director Errol Taylor as new chief executive

The Royal Society for the Prevention of Accidents’ Board of Trustees is delighted to announce the appointment of Errol Taylor as the charity’s new chief executive.

Errol, who has been leading the organisation in an interim capacity since November 2016, joined RoSPA in 2004, initially heading up RoSPA’s commercial activities before developing the case for accident prevention as a public health priority and establishing RoSPA’s Ofqual-recognised qualifications business. He has been RoSPA’s deputy chief executive since 2006.

RoSPA is currently marking its centenary and highlights so far have included the launch of a RoSPA exhibition at the iconic Library of Birmingham, a visit by HRH The Duke of York and the RoSPA Centenary Royal Garden Party at Buckingham Palace. RoSPA is also leading the development of a National Accident Prevention Strategy.

Errol Taylor said:

“I am honoured to become chief executive of RoSPA, particularly at what is such an important time for our charity. We have always been clear that our centenary should not just be an opportunity to look back and highlight past successes, but that it should also be focused firmly on the challenges that remain in accident prevention. Accidents disproportionately affect the most vulnerable members of our society – those who are young, old or disadvantaged – and this is something that we are working tirelessly to address. I am proud to lead a fantastic team of dedicated colleagues and look forward to continuing to develop RoSPA’s valued relationships with other individuals and organisations across the health and safety community.”

Mike Parker, chairman of RoSPA’s Board of Trustees, said:

“The Board believes that Errol’s passion for accident prevention, energy, skills and experience will ensure RoSPA’s continued success for the foreseeable future. His enthusiasm for working in partnership with RoSPA’s many like-minded stakeholder organisations should, in time, lead to a significant reduction in the burden of accidental injury.”

Prior to RoSPA, Errol enjoyed senior customer-facing roles within the services, engineering and retail sectors. A Fellow of both the Institute of Directors (IoD) and the Royal Society for Public Health (RSPH), he is qualified as a Chartered Director with an MBA, an engineering degree and he is a gold grade RoSPA advanced driver. Married with three grown-up children, Errol is an advanced scuba diver who also enjoys cycling.

Errol succeeds Tom Mullarkey MBE, who decided to stand down after nearly 11 years as chief executive. During this period, Tom successfully led the RoSPA team through some difficult financial and business challenges and more recently, in efforts to have the value of accident prevention recognised fully by political and healthcare influencers. Errol said:

“We are grateful for Tom’s valuable contribution and the firm foundation that it provides for us to look ahead with renewed vigour, boldly stating that accidents do not have to happen.”

Jul 292015
 

Novogen appoints Chartered Director Iain Ross as acting CEO and re-appoints him to the Board

Iain RossSydney, July 22, 2015 - Novogen Limited (ASX:NRT; NASDAQ: NVGN), a US-Australian drug development company, today announced the appointment to the Board of Iain Ross, an experienced multi-national pharmaceutical and biotechnology executive. Mr Ross, a former director of Novogen Limited will re-join the Board with immediate effect and take on the role of Acting Chief Executive until a permanent appointment is made.

Mr Ross is currently Chairman of Premier Veterinary Group PLC (formerly Ark Therapeutics PLC), a non-executive director of Amarantus Bioscience Holdings Inc and a non-executive director for ASX-listed companies Anatara Lifesciences Ltd, Benitec Biopharma Ltd and Tissue Therapies Ltd.

Following a career with multinational companies, Sandoz AG, Hoffman La Roche and Celltech Group plc, Mr Ross has over the past 20 years undertaken a number of company start-ups, turnarounds and exits as a Board member on behalf of private equity groups and banks. These include Quadrant Healthcare PLC (sold to Elan); Eden BioDesign (sold to Watson Pharmaceuticals); Phadia AB (sold to Cinven); SR Pharma PLC (merged with Atugen AG to form Silence Therapeutics PLC) Allergy Therapeutics Limited (prepared for IPO); and Ark Therapeutics PLC (subsidiaries sold off to private equity and a new business reversed in to form Premier Veterinary Group PLC).

Mr Ross brings to this role an impressive track record which includes multiple financing transactions, having raised more than £250m, both publicly and privately, as well as extensive experience in divestments and strategic restructures and more than 20 years in cross border management as a Chairman and CEO. He has led and participated in five IPOs on the London and Australian Stock Exchanges and two up-listings to NASDAQ, and has direct experience of M&A transactions in Europe, the US and Pacific Rim. He is a qualified Chartered Director and Vice Chairman of the Council of Royal Holloway, London University.

%d bloggers like this: